Medicinal Chemistry (MDC)

Journal Menu

Journal Browser

Special Issue on Multidisciplinary Sciences and Advanced Technology 2026
Guest Editors: Prof. Paul Andrew
Deadline: December 31, 2026

Special Issue on Advances in Engineering, Computing and Physical Sciences
Guest Editors: Dr. Pallavi Ranja, Dr. Horace Charles Mingo, Dr. Taif Alawsi, Dr. Ercan Atagü, Prof. Sergey V. Parshi, Mr. Hari K.C, Dr. Mohammad Karimi, Prof. Erdal Fıra, Mr. Ginanjar Wiro Sasmito, Dr. Ahmed Salman Ibraheem, Mr. Istiaq Ahmed, Dr. Ku Noor Dhaniah Ku Muhse, Dr. Tan Woan We, Dr. Mohsen Mhadhbi, Dr. Yasir Bu, Dr. Abdelkarim Ballouti, Prof. Noureddine Boumdouha, Dr. Alejandro Medina Santiago, Dr. Priyanka Kajal, Dr. Emmanuel Ampoma Affum, Mr. Rahul Singh, Dr. Kamal Yazzif, Dr. Ziyong Li, Prof. Suroor Moaid Dawood
Deadline: June 30, 2027

Special Issue on Advances in Life, Health and Biomedical Sciences
Guest Editors: Dr. Rajarshi Patel, Dr. Sarah Rajabi, Mr. Shrawan Kumar Singh, Miss Sonia Singla, Miss Sneha Thomas, Mr. Philip Ugbede Ojo Onuche, Dr. Ruchi Pathania, Dr. Ke Zhao, Dr. Omotese I. Oaikhena
Deadline: June 30, 2027

Special Issue on Sustainable Environment, Agriculture, Earth and Society
Guest Editors: Mr. Abdullah All Mamun Anik
Deadline: June 30, 2027

Special Issue on Artificial Intelligence for Energy Transition and Decarbonization 2026
Guest Editors: Dr. Elkhatib Kamal, Dr. Reza Ghorbani, Dr. Ahmed Ragab, Prof. Mohamed Kouki
Deadline: July 31, 2027

Medicinal Chemistry (MDC)

Section Information

Medicinal Chemistry focuses on the design, synthesis, and optimization of biologically active molecules for therapeutic use. It links chemistry with biology, pharmacology, and computational science to understand how chemical structure influences activity, selectivity, and safety.

Modern medicinal chemistry uses structure-based design, high-throughput screening, computational modeling, and analytical methods to discover new drug candidates and improve existing ones. These approaches support the development of small molecules, peptides, and hybrid compounds targeting diseases across human health.

This section will publish research articles, short communications, and reviews on drug discovery, lead optimization, structure–activity relationships, pharmacokinetics, chemical biology tools, natural products, and innovative strategies for therapeutic development.

Scope
  • Drug Design and Discovery Strategies
    • Target identification, validation, and hit discovery
    • Fragment-based, structure-based, and ligand-based design
    • High-throughput and virtual screening approaches
    • Multitarget and systems-oriented drug design
  • Lead Optimization and SAR Studies
    • Structure–activity relationships and chemical optimization
    • Molecular modifications for potency, selectivity, and safety
    • Prodrugs, bioisosteres, and scaffold optimization
    • Physicochemical tuning for drug-like properties
  • Pharmacokinetics, ADME, and Toxicology
    • Absorption, distribution, metabolism, and excretion studies
    • Metabolic stability, soft spot analysis, and metabolite ID
    • Drug–drug interactions and toxicity prediction
    • In vitro and in vivo profiling for safety and efficacy
  • Chemical Biology and Mechanistic Studies
    • Mode-of-action studies and target engagement
    • Covalent inhibitors and reactive warheads
    • Chemical probes for biological pathway interrogation
    • Bioconjugates, probes, and modulators of biomolecules
  • Bioactive Natural Products and Derivatives
    • Isolation, structural characterization, and semi-synthesis
    • Natural product-inspired drug design
    • Complex scaffolds and privileged structures
    • Optimization of natural molecules for therapeutic use
  • Peptides, Peptidomimetics, and Biotherapeutics
    • Design and synthesis of peptides and modified backbones
    • Stability, permeability, and delivery improvements
    • Peptide–drug conjugates and targeted delivery systems
    • Hybrid molecules and macrocycles
  • Computational and Data-Driven Medicinal Chemistry
    • Molecular modeling, docking, and dynamics simulations
    • QSAR, machine learning, and predictive modeling
    • In silico ADME/Tox screening
    • AI-assisted drug discovery workflows
  • Therapeutic Areas and Applications
    • Anti-infective, anticancer, anti-inflammatory, and CNS drugs
    • Cardiovascular, metabolic, and rare disease therapeutics
    • Host–pathogen interactions and resistance mechanisms
    • Precision medicine and personalized therapeutic strategies
  • Analytical and Synthetic Methods in Medicinal Chemistry
    • Modern synthetic techniques, catalysis, and green chemistry
    • Chiral synthesis, purification, and stereochemical control
    • Analytical characterization and method development
    • Automation, flow chemistry, and high-throughput synthesis
Editorial Board

Click here to see the Section Editorial Board of “Medicinal Chemistry (MDC)”.

Topical Advisory Panel

Click here to see the Section Topical Advisory Panel of “Medicinal Chemistry (MDC)”.

Papers Published

Click here to see a list of 0 papers published in this section.

Share Link